Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway

Liu,Tielong; Zhou,Weiwei; Zhang,Fei; Shi,Guodong; Teng,Honglin; Xiao,Jianru; Wang,Yan

doi:10.3892/mmr.2014.2215

Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway

Authors:
- Tielong Liu
- Weiwei Zhou
- Fei Zhang
- Guodong Shi
- Honglin Teng
- Jianru Xiao
- Yan Wang
View Affiliations

Affiliations: Department of Orthopedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Radiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Orthopedics, Ningbo Development Zone Center Hospital, Ningbo, Zhejiang 315800, P.R. China, Department of Orthopedics, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Orthopedics, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China
Published online on: May 7, 2014 https://doi.org/10.3892/mmr.2014.2215
Pages: 169-174

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma is the most common type of human primary malignant bone tumor with a potential propensity for local invasion and distant metastasis. Thus, this study focused on the expression and roles of IRX2 in the development of osteosarcoma. The mRNA expression levels of IRX2 in tissue samples of 69 cases of human osteosarcoma were detected by a quantitative polymerase chain reaction assay. The associations between the expression levels of IRX2 and the pathological features of the tumor tissues were analyzed. Functional studies were performed by MTT and Matrigel invasion assays following IRX2 knockdown with a lentivirus vector. Western blotting was used to assay the protein expression levels of IRX2, p‑AKT and matrix metalloproteinases (MMP). The results revealed that the expression levels of IRX2 were significantly increased in the primary human osteosarcoma tissues compared with those in the normal tissues, and the increase was significantly correlated with the tumor progression and prognosis of the patients. Furthermore, the proliferation and invasion of the cells were suppressed following IRX2 knockdown. Additionally, the mechanism by which IRX2 promoted cell proliferation and invasion by activating AKT and MMP9 was detected. In conclusion, these results indicated that IRX2 promotes proliferation and invasion in osteosarcoma and implicated the potential of IRX2 in cancer therapy.

View Figures

View References

1	Kansara M and Thomas DM: Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007. View Article : Google Scholar
2	Broadhead ML, Clark JC, Myers DE, Dass CR and Choong PF: The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
3	Khanna C, Wan X, Bose S, et al: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 10:182–186. 2004. View Article : Google Scholar : PubMed/NCBI
4	Zhang P, Yang Y, Zweidler-McKay PA and Hughes DP: Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res. 14:2962–2969. 2008. View Article : Google Scholar : PubMed/NCBI
5	Su Y, Wagner ER, Luo Q, et al: Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene. 30:3907–3917. 2011. View Article : Google Scholar : PubMed/NCBI
6	Zhang P, Yang Y, Zweidler-McKay PA and Hughes DP: Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res. 14:2962–2969. 2008. View Article : Google Scholar : PubMed/NCBI
7	Ando T, Ichikawa J, Okamoto A, Tasaka K, Nakao A and Hamada Y: Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines. J Orthop Res. 23:964–969. 2005. View Article : Google Scholar : PubMed/NCBI
8	Kim SM, Lee H, Park YS, Lee Y and Seo SW: ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. J Orthop Res. 30:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
9	Gvozdenovic A, Arlt MJ, Campanile C, et al: CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome. J Bone Miner Res. 28:838–847. 2013. View Article : Google Scholar : PubMed/NCBI
10	Liu X, Choy E, Hornicek FJ, et al: ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang SW, Wu HH, Liu SC, et al: CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLoS One. 7:e351012012. View Article : Google Scholar : PubMed/NCBI
12	Kang H, Wilson CS, Harvey RC, et al: Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood. 119:1872–1881. 2012.PubMed/NCBI
13	Kadota M, Sato M, Duncan B, et al: Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. Cancer Res. 69:7357–7365. 2009. View Article : Google Scholar : PubMed/NCBI
14	Adamowicz M, Radlwimmer B, Rieker RJ, et al: Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer. 45:829–838. 2006. View Article : Google Scholar : PubMed/NCBI
15	Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD and Pfeifer GP: DNA methylation biomarkers for lung cancer. Tumour Biol. 33:287–296. 2012. View Article : Google Scholar : PubMed/NCBI
16	Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433. 2000. View Article : Google Scholar : PubMed/NCBI
17	Xue G, Restuccia DF, Lan Q, et al: Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. Cancer Discov. 2:248–259. 2012.PubMed/NCBI
18	Teranishi F, Takahashi N, Gao N, et al: Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo. Cancer Sci. 100:770–777. 2009. View Article : Google Scholar : PubMed/NCBI
19	Fang Y, Xue JL, Shen Q, Chen J and Tian L: MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
20	Lu Y and Wahl LM: Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J Leukoc Biol. 78:259–265. 2005. View Article : Google Scholar : PubMed/NCBI
21	Gustin JA, Ozes ON, Akca H, et al: Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem. 279:1615–1620. 2004. View Article : Google Scholar : PubMed/NCBI